Last updated on January 2015

Japanese Phase Ib/II Copanlisib in Relapsed Indolent B-cell NHL


Brief description of study

The primary objective of this study is to assess the safety profile of copanlisib at the recommended dose (primary endpoint). The recommended dose of copanlisib for Japanese patients will be determined in the dose escalation/safety evaluation part

Clinical Study Identifier: NCT02342665

Contact Investigators or Research Sites near you

Start Over